Skip to content
TrackPodcasts
businessJan 7, 202630:53pending

Can a GLP-1 Pill Revive Novo Nordisk?

Prof G Markets

About this episode

Ed Elson speaks with Alex Heath, host of the ACCESS Podcast, about why Nvidia is dominating the news out of the CES conference. Then Jared Holz, Healthcare Equity Strategist at Mizuho, joins the show to discuss what Novo Nordisk’s new Wegovy pill means for the healthcare industry.  Check out our latest Prof G Markets newsletter Follow Prof G Markets on Instagram Follow Ed on Instagram, X and Substack Follow Scott on Instagram Learn more about your ad choices. Visit podcastchoices.com/adchoices

Get every episode summarized

Each time Prof G Markets publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Can a GLP-1 Pill Revive Novo Nordisk?

Prof G Markets

0:00
30:53

More episodes

More from Prof G Markets

View all episodes →